Literature DB >> 22218957

Modification of lipoprotein(a) by natural dicarbonyls induced their following free radical peroxidation.

V Z Lankin1, O I Afanasieva, G G Konovalova, E A Utkina, O A Dmitrieva, A K Tikhaze, E M Kumskova, S N Pokrovsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22218957     DOI： 10.1134/S1607672911060159

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  10 in total

Review 1.  Lipoprotein(a): intrigues and insights.

Authors:  H H Hobbs; A L White
Journal:  Curr Opin Lipidol       Date:  1999-06       Impact factor: 4.776

2.  [An immunoenzyme method for determining lipoprotein(a)].

Authors:  O I Afanas'eva; I Iu Adamova; G F Benevolenskaia; S N Pokrovskiĭ
Journal:  Biull Eksp Biol Med       Date:  1995-10

Review 3.  Apolipoprotein(a): structure and biology.

Authors:  A M Scanu; K Nakajima; C Edelstein
Journal:  Front Biosci       Date:  2001-03-01

Review 4.  Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.

Authors:  Sebhat Erqou; Stephen Kaptoge; Philip L Perry; Emanuele Di Angelantonio; Alexander Thompson; Ian R White; Santica M Marcovina; Rory Collins; Simon G Thompson; John Danesh
Journal:  JAMA       Date:  2009-07-22       Impact factor: 56.272

5.  Association of lipoprotein(a) excess with early vein graft occlusions in middle-aged men undergoing coronary artery bypass surgery.

Authors:  Sergei N Pokrovsky; Marat V Ezhov; Larisa N Il'ina; Olga I Afanasieva; Valentin Y Sinitsyn; Andrey A Shiriaev; Renat S Akchurin
Journal:  J Thorac Cardiovasc Surg       Date:  2003-10       Impact factor: 5.209

6.  Continuous monitoring of in vitro oxidation of human low density lipoprotein.

Authors:  H Esterbauer; G Striegl; H Puhl; M Rotheneder
Journal:  Free Radic Res Commun       Date:  1989

7.  A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma.

Authors:  Claes Bergmark; Asheesh Dewan; Alexina Orsoni; Esther Merki; Elizabeth R Miller; Min-Jeong Shin; Christoph J Binder; Sohvi Hörkkö; Ronald M Krauss; M John Chapman; Joseph L Witztum; Sotirios Tsimikas
Journal:  J Lipid Res       Date:  2008-07-01       Impact factor: 5.922

8.  Immunosorbent for selective removal of lipoprotein (a) from human plasma: in vitro study.

Authors:  S N Pokrovsky; O Y Afanasieva; G F Benevolenskaya
Journal:  Artif Organs       Date:  1991-04       Impact factor: 3.094

9.  Lipoprotein(a) as a cardiovascular risk factor: current status.

Authors:  Børge G Nordestgaard; M John Chapman; Kausik Ray; Jan Borén; Felicita Andreotti; Gerald F Watts; Henry Ginsberg; Pierre Amarenco; Alberico Catapano; Olivier S Descamps; Edward Fisher; Petri T Kovanen; Jan Albert Kuivenhoven; Philippe Lesnik; Luis Masana; Zeljko Reiner; Marja-Riitta Taskinen; Lale Tokgözoglu; Anne Tybjærg-Hansen
Journal:  Eur Heart J       Date:  2010-10-21       Impact factor: 29.983

10.  Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008.

Authors:  Markku Laakso
Journal:  Diabetes Care       Date:  2010-02       Impact factor: 19.112
  10 in total
  1 in total

1.  Impact of Atherosclerosis- and Diabetes-Related Dicarbonyls on Vascular Endothelial Permeability: A Comparative Assessment.

Authors:  Mikhail V Samsonov; Asker Y Khapchaev; Alexander V Vorotnikov; Tatyana N Vlasik; Elena V Yanushevskaya; Maria V Sidorova; Evgeniy E Efremov; Vadim Z Lankin; Vladimir P Shirinsky
Journal:  Oxid Med Cell Longev       Date:  2017-10-02       Impact factor: 6.543
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.